All Stories

  1. Systemic activation of contact phase
  2. An Arg378Cys variant of SERPING1 gene with unusual characteristics
  3. C1 Inhibitor
  4. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013
  5. Transfusion-related acute lung injury: critical neutrophil activation by anti-HLA-A2 antibodies for endothelial permeability
  6. Hereditary C1 inhibitor deficiency is associated with high spontaneous amidase activity
  7. Kininogen Cleavage Assay: Diagnostic Assistance for Kinin-Mediated Angioedema Conditions
  8. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
  9. A nationwide study of acquired C1-inhibitor deficiency in France
  10. Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process
  11. C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target
  12. Molecular identification of C3 deficient families
  13. Dysregulation of adaptive immune responses in complement C3-deficient patients
  14. Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
  15. Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency
  16. Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema
  17. Hereditary angioedema withF12mutation: factors modifying the clinical phenotype
  18. Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation
  19. Liste des collaborateurs
  20. Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation
  21. Contact System Activation in Patients with HAE and Normal C1 Inhibitor Function
  22. Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: A multifactorial disease
  23. Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
  24. Estrogen-independent hereditary angioedema with normal C1 inhibitor function in a 10-year-old boy
  25. Reply
  26. Angio-œdèmes bradykiniques (AOBK) attribués à des anti-androgènes chez l’homme : deux cas
  27. Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel
  28. The CD46-Jagged1 interaction is critical for human TH1 immunity
  29. Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
  30. Methylene blue–treated plasma: An increased allergy risk?
  31. Actualités biologiques sur les angioedèmes à kinines
  32. Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab
  33. Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation
  34. One hypovolaemic shock…two kinin pathway abnormalities
  35. A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation
  36. BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS
  37. Human C3 deficiency shares characteristics with common variable immune deficiency
  38. Disease expression in women with hereditary angioedema
  39. Biosynthesis of C1 inhibitor in the contexts of angioedema and HCV infection
  40. Functional C1-Inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendations
  41. Plasma metallopeptidases are involved in hereditary angioedema with C1 Inhibitor deficiency.
  42. Interactions Between Human Plasma Components and A Xenogenic Adenovirus Vector: Reduced Immunogenicity During Gene Transfer
  43. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene
  44. Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III
  45. Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma
  46. Functional analysis of splicing mutations and of an exon 2 polymorphic variant ofSERPING1/C1NH
  47. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
  48. Clinical and biological distinctions between type I and type II acquired angioedema
  49. Detection of Antiendothelial Cell Antibodies by an Enzyme-Linked Immunosorbent Assay Using Antigens from Cell Lysate: Minimal Interference with Antinuclear Antibodies and Rheumatoid Factors
  50. Angioedema and Oral Contraception
  51. Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity
  52. NS3 protease of Langat tick-borne flavivirus cleaves serine protease substrates
  53. Complement C4 monitoring in the follow-up of chronic hepatitis C treatment
  54. Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts
  55. Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection
  56. Chronic restraint stress induces severe disruption of the T-cell specific response to tetanus toxin vaccine
  57. Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes
  58. Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor
  59. Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts
  60. Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases
  61. EBV-B cells as antigen presenting cells in characterization of the self/donor context of allorecognition by T lymphocytes
  62. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations.
  63. Monoclonal IgG as antigens: reduction is an early intracellular event of their processing by antigen-presenting cells
  64. Contribution of apoptosis to the phenotypic changes of adrenocortical cells in primary culture
  65. Tetanus toxin light chain recognition by CD4+ and CD8+ human T cell clones
  66. Non-Coordinated Biosynthesis of Early Complement Components in a Deficiency of Complement Proteins Clr and Cls
  67. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells
  68. OH• treatment of tetanus toxin reduces its susceptibility to limited proteolysis with more efficient presentation to specific T cells
  69. The interaction of antigenic peptides with the H-2Kd MHC class I molecule
  70. Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution
  71. Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis
  72. A sensitive method to assay blood complement C Inhibitor activity